YRC Logo
PROTEIN SEARCH:
Descriptions Names[Advanced Search]

Any process that modulates the frequency, rate, or extent of myeloid leukocyte mediated immunity. An inflammatory response resulting from recognition of immune complexes via complement or Fc receptors on effector cells leading to activation of neutrophils and other leukocytes and damage to bystander tissue. An immune response mediated by immunoglobulins, whether cell-bound or in solution. An inflammatory response to an exogenous environmental antigen or an endogenous antigen initiated by the adaptive immune system. Any process that modulates the frequency, rate, or extent of an immunoglobulin mediated immune response. Any process involved in the carrying out of an immune response by a myeloid leukocyte. Any process that modulates the frequency, rate, or extent of an acute inflammatory response to an antigenic stimulus. Any process that modulates the frequency, rate, or extent of B cell mediated immunity. Any process that modulates the frequency, rate, or extent of type III hypersensitivity, a type of inflammatory response. Any process that stops, prevents, or reduces the rate of type III hypersensitivity, a type of inflammatory response. Any process that modulates the frequency, rate, or extent of leukocyte mediated immunity. Any process that activates or increases the frequency, rate or extent of type III hypersensitivity, a type of inflammatory response. Any process that modulates the frequency, rate, or extent of hypersensitivity.

View Gene Ontology (GO) Term

GO TERM SUMMARY
Name: regulation of type III hypersensitivity
Acc: GO:0001803
Aspect: Biological Process
Desc: Any process that modulates the frequency, rate, or extent of type III hypersensitivity, a type of inflammatory response.
Proteins in PDR annotated with:
   This term: 0
   Term or descendants: 6 [Search]


[geneontology.org]
INTERACTIVE GO GRAPH

GO:0001803 - regulation of type III hypersensitivity (interactive image map)
YRC Informatics Platform - Version 3.0
Created and Maintained by: Michael Riffle